Turning Drug Resistance Against Itself

Stony Brook-led research exploits DNA amplification in cancer to halt chemoresistance

Check out the Stony Brook University News article here!

Gábor Balázsi, in his Biomedical Engineering laboratory with Rafal Krzysztoń, PhD, and Yiming Wan, PhD, both first co-authors on the PNAS paper.
Credit: John Griffin, Stony Brook University

Previous
Previous

Eugene Serebryany: Cracking the Code at the NSF Ideas Lab on Protein Design!